Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-09-05
1999-08-17
Huff, Sheela
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
4241301, 530300, A61K 3800, A61K 39395
Patent
active
059393874
ABSTRACT:
The present invention is in the field of human medicine, particularly in the treatment of Non-insulin Dependent Diabetes Mellitus (NIDDM) and other insulin resistant states such as those associated with obesity and aging. The invention provides a method of treating insulin resistant mammals, which comprises administering to a mammal in need thereof a growth hormone releasing agent.
REFERENCES:
patent: 4988675 (1991-01-01), Froesch et al.
patent: 5093317 (1992-03-01), Lewis et al.
patent: 5126324 (1992-06-01), Clark et al.
patent: 5187151 (1993-02-01), Clark et al.
Gregon'adis,G. et al. 1993. Trends in Biotech 11:440-442.
Richards,NT. 1984. Diabetologia, 27: 529-534.
Martina, V. et al. 1995. Horm. Metab. Res. 27:26-30.
Rudman et al., 1990 New Eng. J. Med., 323(1):1-6.
Salomon et al. 1989, New Eng. J. Med., 321(26):1797-1803.
Marcus et al., 1990 J. Clin. End. Met., 70(2):519-527.
Jorgensen et al., 1989, Lancet, Jun. 3:1221-1225.
Binnerts et al., 1988, J. Clin. End. Met., 67(6):1312-1316.
Hammerman, M.R., 1987, Endocrin. Meta. Clin., 16(4):995-1011.
Rudman et al., 1987, Gerontology, 33:307-314.
Dietz et al., 1986, Am. J. Clin. Nutr., 43(4):696.
Rudman, D., 1985, J. Am. Ger. Soc., 33(11):800-807.
Sonntag et al., 1985, J. Gerontol., 40(6):689-694.
Rudman et al., 1981, J. Clin.Invest., 67;1361-1369.
Johanson et al., 1981, Johns Hopkins Med. J., 149:115-117.
Root et al., 1969, J. Gerontol., 24:97-103.
Clark et al., 1996, 10th International Congress of Endocrinology, Abstracts, No. P1-591.
Bowers, C.Y., J. Pediatr. Endocrin.,6(1), pp. 21-31, 1993.
Rizza, et al., Diabetes, vol. 31, pp. 663-669, Aug. 1982.
Giustina et al., TEM, vol. 5, No. 1, pp. 73-78, 1994.
Rosenfeld et al., J. of Clin. Endo. and Metab., vol. 54, No. 5, pp. 1033-1038, 1982.
Davidson, M. B., Endocrine Reviews, vol. 8, No. 2, pp. 115-131, 1987.
Thorner, M.O., Acta Paediatr Suppl. 388:2-7, 1993.
Frohman et al., Endocrine Reviews, vol. 7, No. 3, pp. 223-253, 1986.
Diequez et al., TEM vol. 6, No. 2, pp. 55-59, 1995.
Johansson, et al., Metabolism, vol. 45(3), 1996:pp. 362-369.
Broderick Carol Lynn
DiMarchi Richard Dennis
Heiman Mark Louis
Stramm Lawrence Edward
Caltrider Steven P.
Eli Lilly and Company
Eyler Yvonne
Huff Sheela
Maciak Robert S.
LandOfFree
Method of treating insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating insulin resistance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-314823